Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 1 | -3.41K | 100% | $0.73 | -$2.49K |
Net | -1 | -3.41K | -100% | -$2.49K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
IVor Royston | Director | $665K | Nov 25, 2024 | ||
Roger Pomerantz | Director | $106K | Nov 25, 2024 | ||
Daniel R. Chevallard | CFO and COO | $91.9K | -$2.49K | -2.64% | Mar 12, 2024 |
Lisa Rojkjaer | Chief Medical Officer | $77.6K | Mar 16, 2023 | ||
Mark Rothera | President and CEO, Director | $49.3K | Mar 12, 2024 | ||
Flavia Borellini | Director | Jun 20, 2024 | |||
Stephen Rubino | Director | Jun 20, 2024 | |||
Jane F. Barlow | Director | Jun 20, 2024 | |||
Thomas E. Darcy | Director | Jun 20, 2024 | |||
Michael Huang | Director | Jun 9, 2022 | |||
Samuel Lafayette Murphy | Director | Jun 20, 2024 | |||
Nicole Onetto | Director | Jun 9, 2022 | |||
Darrel P. Cohen | Chief Medical Officer | Mar 12, 2024 | |||
Melody Burcar | Senior VP, Finance | Mar 20, 2024 | |||
Barry J. Simon | Director | Jun 20, 2024 | |||
Jane Chung | Director | Jun 20, 2024 | |||
Michael E. Faerm | Chief Financial Officer | May 14, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|